This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James A. Neidhart, MD; Albert F. LoBuglio, MD

Arch Otolaryngol. 1975;101(11):664-666.

Abstract
• Transfer factor (TF) is a low molecular weight nonantigenic extract of leukocytes that is capable of transferring cell-mediated immunity from an immune individual to a nonimmune individual. Reports of efficacy of transfer factor in immunodeficiency states and chronic infectious diseases, as well as its lack of toxicity, have spurred clinical trials of TF therapy in human malignant diseases. Variables such as donor and patient selection, dose of TF, and use of concurrent therapy have not been explored. Preliminary reports suggest that TF may find a role as adjuvant therapy in human malignant neoplasms.

(Arch Otolaryngol 101:664-666, 1975)

Author Affiliations
From the Division of Hematology and Oncology, Ohio State University College of Medicine, Columbus.

Footnotes
Accepted for publication July 3, 1975.

Read before the 17th annual meeting of the American Society for Head and Neck Surgery, Atlanta, April 9, 1975.

Reprint requests to University Hospital, N1031,410 W Tenth St, Columbus, OH 43210 (Dr Neidhart).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?